/Globe%20Life%20Logo%20on%20Phone%20Screen%2C%20Company%20Icon%20By%20Postmodern%20Studio.jpeg)
With a market cap of $13.9 billion, Globe Life Inc. (GL) provides life insurance, supplemental health insurance, and annuity products primarily to lower middle- and middle-income families. It operates through Life Insurance, Supplemental Health Insurance, and Investment segments, distributing its products via direct-to-consumer channels, exclusive agencies, and independent agents.
Shares of the life and health insurance company have outperformed the broader market over the past 52 weeks. GL stock has increased 30.6% over this time, while the broader S&P 500 Index ($SPX) has rallied 20.7%. Moreover, the stock is up 29.4% on a YTD basis, compared to SPX’s 14% gain.
Focusing more closely, shares of the McKinney, Texas-based company have also outpaced the State Street Financial Select Sector SPDR ETF's (XLF) 9.7% return over the past 52 weeks and a 6.2% YTD rise.
Globe Life’s shares dropped over 7% on Jul. 22 as investors focused on weak sales trends despite the Q2 2026 earnings beat, with total life net sales down 3%, direct-to-consumer life sales down 15%, and American Income life sales down 2%. Sentiment was further pressured by a 7% decline in American Income’s average producing agent count and weak underwriting trends, with health underwriting income rising only 1% while margins fell at United American (12%), American Income (6%), and Liberty National (5%).
Although Q2 2026 EPS of $3.65 beat estimates and revenue rose 7.4% to $1.59 billion, the softer sales and underwriting performance overshadowed the earnings strength.
For the fiscal year ending in December 2026, analysts expect Globe Life’s EPS to grow 8.2% year-over-year to $15.71. The company's earnings surprise history is mixed. It topped the consensus estimates in one of the last four quarters while missing on three other occasions.
Among the 15 analysts covering the stock, the consensus rating is a “Moderate Buy.” That’s based on eight “Strong Buys,” two “Moderate Buys,” and five “Holds.”
This configuration has remained unchanged over the past three months.
On Jul. 25, Truist Financial analyst Mark Hughes maintained a “Buy” rating on Globe Life with a $185 price target.
The mean price target of $192.64 represents a 6.4% premium to GL's current levels. The Street-high price target of $225 implies a potential upside of 24.3%.
On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
/Netflix%20on%20tv%20with%20remote%20by%20freestocks%20via%20Unsplash.jpg)
